HEC Trends
Share new trends in technology and health
HEC Trends
Share new trends in technology and health

Wen Wenxing, Secretary of the Party Committee and Chairman of Guangdong Hengjian Investment Holding Co., Ltd. led a team to inspect HEC Group

2021-08-12

On the afternoon of August 11, 2021, Wen Wenxing, Secretary of the Party Committee and Chairman of Guangdong Hengjian Investment Holding Co., Ltd., led a team to inspect HEC Group. Zhang Yushuai, Chairman of HEC Group, and Tang Xinfa, Director of HEC Group and Dean of the Research Institute, accompanied and participated in the symposium.

Guangdong Hengjian Investment Holding Co., Ltd. (hereinafter referred to as "Guangdong Hengjian") is the only state-owned capital operation company and platform integrating industry and finance in Guangdong Province. Its main business sectors include capital operation, fund investment, and equity management, and is the provincial enterprise group with the largest net assets and the strongest capital strength in the province.

(Picture 1: Wen Wenxing, Secretary of the Party Committee and Chairman of Guangdong Hengjian Investment Holdings Co., Lt)

(Picture 2: Zhang Yushuai, Chairman of HEC Group)

HEC has already carried out close cooperation and communication with several funds such as Guangdong Advanced Manufacturing Industry Investment Fund under Guangdong Hengjian, Guangdong Guangdong-Macao Cooperation Development Fund, and Guangdong Traditional Chinese Medicine Great Health Equity Investment Fund. After the high-level exchanges between the two parties, the two parties intend to integrate superior resources, further deepen cooperation in the fields of industrial upgrading and capital operation, improve the operating efficiency of both companies, achieve win-win cooperation, and make more contributions to the local social and economic development.

During the inspection, Tang Xinfa, director of HEC Group and dean of the Research Institute, accompanied to introduce the research institute.


Related news

Hengjian strategically invests in shares to help HEC take off

2021-02-04

On February 2, 2021, Sunshine Group and Guangdong Hengjian Investment Holding Co., Ltd. (hereinafter referred to as "Guangdong Hengjian") formally reached a strategic cooperation. Guangdong Hengjian strategically invested in Guangdong Sunshine Pharmaceutical through its Guangdong Advanced Manufacturing Fund. Co., Ltd. (hereinafter referred to as "Tongyang Research"), with an investment amount of RMB 600 million and has completed the industrial and commercial change and payment procedures. This time, Guangdong Hengjian, as one of the cornerstone investors and leading investors, actively participated in this round of financing of HERO by introducing strategic investors, which shows Guangdong Hengjian's high recognition of HERO's strength, value and future development. This marks a major progress in the introduction and securitization work of TOC Research.